IDF21-0679 INTENSIFY: effectiveness of insulin degludec/liraglutide (IDegLira) in a real-world T2DM population in the UAE

Journal article

Open access

Peer reviewed

F. Al Awadi, H. Aly, A. Bashier, J. Medina Benavente, D. Kumar Dhanwal, M. Jallo, S. Singhal and S. Abusnana

Diabetes research and clinical practice, Vol.186, p.109620

04/2022

Files and links (1)

url

https://doi.org/10.1016/j.diabres.2022.109620View

Published (Version of record) Open

1 Record Views

Title: IDF21-0679 INTENSIFY: effectiveness of insulin degludec/liraglutide (IDegLira) in a real-world T2DM population in the UAE
Creators - without role: F. Al Awadi - Dubai Hospital
H. Aly - Novo Nordisk Pharmaceutical Company, Clinical, Medical, Regulatory Affairs & Quality, Dubai, United Arab Emirates
A. Bashier - Dubai Hospital
J. Medina Benavente - Novo Nordisk A/S, Endocrinology, Søborg, Denmark
D. Kumar Dhanwal - Northwestern Michigan College
M. Jallo - Gulf Medical University
S. Singhal - Novo Nordisk, Clinical, Medical, Regulatory Affairs & Quality, Dubai, United Arab Emirates
S. Abusnana - University of Sharjah
Publication Details: Diabetes research and clinical practice, Vol.186, p.109620
Publisher: Elsevier B.V
Identifiers: 9936533508331
Academic Unit: King Abdulaziz University
Language: English
Resource Type: Journal article